Actively Recruiting
EndoPAT Device for Endothelial Dysfunction in ED
Led by University of California, Irvine · Updated on 2026-02-02
120
Participants Needed
1
Research Sites
72 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy
CONDITIONS
Official Title
EndoPAT Device for Endothelial Dysfunction in ED
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males 18 years old and above
- Diagnosed with erectile dysfunction or hypogonadism
You will not qualify if you...
- Patients without the above criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UCI Urology | Men's Health Center
Newport Beach, California, United States, 92660
Actively Recruiting
Research Team
M
Muhammed AM Hammad, MBBCh
CONTACT
E
Elia Abou Chawareb, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here